Edwards Lifesciences Corp. (EW) Posts Mixed Q4 Results
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $89.32 +1.11%
EPS Growth %: +10.4%
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +10.4%
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.62, $0.03 better than the analyst estimate of $0.59. Revenue for the quarter came in at $430.2 million versus the consensus estimate of $446.94 million.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Ennis (EBF) Misses Q2 EPS by 2c
- CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
